# SPRAVATO
> **NDA211243** · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2019-03-05
## Drug
- **FDA Application Number:** NDA211243
- **Application type:** New Drug Application
- **Brand name:** SPRAVATO
- **Generic name:** ESKETAMINE HYDROCHLORIDE
- **Active ingredients:** ESKETAMINE HYDROCHLORIDE
- **Dosage form:** SPRAY
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** JANSSEN PHARMS
- **Manufacturer:** Janssen Pharmaceuticals Inc.
- **First approval:** 2019-03-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211243)
---
*AI Analytics · CC0 1.0*